Jan Elders
Senior Analyst
1101 BE, NL
Jan Elders works as a consultant in the Amsterdam office of Milliman. He joined the firm in 2023.
Experience
Before joining Milliman, Jan graduated from the VU University as a Master of Science: Duisenberg Honours Programme in Quantitative Risk Management.
Education
- Master of Science in Duisenberg Honours Programme in Quantitative Risk Management, VU Amsterdam, The Netherlands
- Bachelor of Science in Economics and Business Economics, Specialization in Finance, University of Amsterdam, The Netherlands
Publications
Read their latest work
Article
EIOPA consultations and the Solvency II review
30 January 2026 - by Conor Callaghan, Neil Christy, Jan Elders, Seán McCaw, Gillian Tucker
Arising from the Solvency II 2020 review, the European Parliament formally adopted amendments to the Solvency II Directive in April 2024. Building on this, the European Commission published the finalised amendments to the Delegated Regulation underpinning the Directive in October 2025.
Article
Milliman 2025 ORSA sustainability benchmarking survey
26 January 2026 - by Adél Drew, Jan Elders, Sandra Heaslip, Amy Nicholson, Nick Spencer
We assessed how European life insurance firms are responding to the intersection of climate-driven inflation and ORSA.
Article
ユーロ圏の長期インフレ:構造的要因とシナリオモデリングにより、インフレの軌跡と保険会社への影響を予測
14 February 2025 - by Jan Elders, Koen Zomerdijk
高齢化する人口、従属比率、気候政策は、長期的なインフレ傾向に重要な影響を及ぼす可能性があります。
Article
The impact of long-term inflation in the Eurozone
14 February 2025 - by Jan Elders, Koen Zomerdijk
Aging populations, the dependency ratio, and climate policies will likely play a critical role in long-term inflationary trends.
Article
オランダの健康保険会社のソルベンシーおよび財務状況報告書の分析:2023年末
06 December 2024 - by Judith Houtepen, Sjoerd van Dieten, Jan Elders, Rens IJsendijk
2023年末のソルベンシーおよび財務状況報告書(SFCR)に基づく、オランダの健康保険会社の分析のハイライトをお伝えします。
Article
Analysing 2023 Solvency and Financial Condition Reports (SFCR) of health insurers in The Netherlands
06 December 2024 - by Judith Houtepen, Sjoerd van Dieten, Jan Elders, Rens IJsendijk
We present the highlights of our analysis of health insurers in the Netherlands, based on 2023 year-end SFCRs.